Based on the above data, the current study investigated the neuroprotective effect of 2, 4-diamino-6-hydroxypyrimidine (DAHP), brain GTPCH-1 inhibitor, against neuronal loss in 3-NP induced HD via iNOS inhibition. Here, NOS2 is linked to Huntington disease.